Atopic Dermatitis

Sleep quality improvement in children treated with dupilumab for atopic dermatitis

November 15th 2022

Dermavant Sciences recently announced positive results for VTAMA (tapinarof cream, 1%) for treatment of atopic dermatitis in children aged as young as 2 years.

Tim Smith

October 25th 2022

New research suggests the sleep quality of caregivers and patients with atopic dermatitis (inadequately-controlled with topical therapies) may improve with dupilumab treatment.

Review examines different ways to reduce costs for atopic dermatitis treatment

Tim Smith

September 30th 2022

A review examined the ways in which costs can be reduced for patients with varying types of atopic dermatitis.

New treatments for atopic dermatitis

Dupilumab safe, effective in long-term pediatric use

September 14th 2022

In a recent article, researchers discussed current atopic dermatitis treatments, along with the need for safe and effective long-term treatments.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

September 13th 2022

Improvements in atopic dermatitis symptoms were seen in children taking dupilumab, with minimal adverse events.

Take-Home Points

Case 3 Continued: How to Have Conversation About Risk of Biologics and Length of Therapy

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 3 Continued: Impressions

Atopic dermatitis specialists discuss how to have a conversation with parents about risks of biologics and how to answer questions about length of therapy.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 3: 12-Year-Old-Female With Atopic Dermatitis

Expert pediatric dermatologists provide impressions on the case of a 12-year-old girl with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Addressing Injectable Medication in Children

Joshua Zeichner, MD, reviews the case of a 12-year-old girl with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Importance of Combination Therapy and Shared Decision Making

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; and Vikash Oza, MD, address techniques for injectables when treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Barriers to Treatment Adherence

Expert pediatric dermatologists discuss the importance of combination therapy and shared decision-making when treating pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2 Continued: Impressions and Recommendations

Brittany Craiglow, MD, and Joshua Zeichner, MD, discuss treatment adherence in pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 2: 7-Year-Old Female With Atopic Dermatitis

Vikash Oza, MD, provides clinical insight for Case 2, a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 1 Continued: Treatments Beyond Topical Agents and the Use of Dupixent

Dr Joshua Zeichner reviews the case of a 7-year-old female patient with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 1 Continued: Clinical Impressions

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, discuss treatments beyond topical agents and the use of dupilumab in pediatric patients with atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Case 1: 2-Year-Old Male With Atopic Dermatitis

Expert pediatric dermatologists Drs Elizabeth Swanson, Joshua Zeichner, and Raj Chovatiya share impressions from patient case No. 1.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Patient Presentation of Atopic Dermatitis

Dr Joshua Zeichner reviews the case of a 2-year-old patient with atopic dermatitis.

Raj Chovatiya, MD, PhD;Elizabeth Swanson, MD;Korey Capozza, MPH

August 24th 2022

Taylor Capps and her mother, Tina Capps, share Taylor’s initial journey with atopic dermatitis and presenting symptoms.

New atopic dermatitis treatments in development

Pharmacological Options for the Treatment of Pediatric Atopic Dermatitis

Children with atopic dermatitis will soon have more options for treatment, as clinical trials show promising results.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Burden of Atopic Dermatitis in Pediatric Patients

Experts treating pediatric atopic dermatitis discuss the pharmacological options for the treatment of pediatric atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Presentation and Diagnosis of Atopic Dermatitis in Pediatrics

Expert pediatric dermatologists Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the burden of pediatric atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Psychological Impact of Atopic Dermatitis in Pediatric Patients

Brittany Craiglow, MD; Raj Chovatiya, MD, PhD; and Joshua Zeichner, MD, discuss the presentation of pediatric patients with atopic dermatitis and how to properly assess and diagnose pediatric patients’ atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Mechanism of Action for Agents Used to Treat Pediatric Atopic Dermatitis

Elizabeth Swanson, MD, and Joshua Zeichner, MD, discuss the psychological factors impacting pediatric patients’ atopic dermatitis.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Characteristics of Type 2 Inflammation and the Impact of Itch

Joshua Zeichner, MD, and Raj Chovatiya, MD, PhD, dive deep into the pathogenesis of atopic dermatitis and discuss how agents treating atopic dermatitis work.

Joshua Zeichner, MD;Brittany Craiglow, MD;Elizabeth Swanson, MD;Vikash Oza, MD;Raj Chovatiya, MD, PhD

Atopic dermatitis negatively impacts family life

Joshua Zeichner, MD, and Vikash Oza, MD, discuss characteristics of type 2 inflammation and the impact of itching on pediatric patients with atopic dermatitis.